In my previous blog post on cytology quality improvement, you and I had an assignment to read this article, Arch Pathol Lab Med. 2011 Nov;135(11):1387-90, Quality improvement in cytology: where do we go from here? by Andrew Renshaw, MD. The time has come to followup on this initial post and discuss the article and provide some conclusions. [...]
Atypical Thyroid Diagnoses-Potential for Overuse?
In a recent editorial published in Cancer Cytopathology, Vol. 120:2, April 25, 2012, Dr. Michael Henry discusses the potential for overuse of atypical thyroid diagnoses according to The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). This journal also includes other articles related to thyroid FNA, interpretation and quality tools (to be discussed in a subsequent [...]
CME Opportunity: AHRQ Webinar on April 11th
I thought this AHRQ Webinar looked interesting. Although it doesn’t directly relate to cytology or pathology, the tools may have a practical application for us. The Webinar information is included below. Please feel free to share your thoughts about the webinar by commenting to this blog post. HHS’s Agency for Healthcare Research and Quality (AHRQ) [...]
Cytology Quality Improvement: Part 1-Read and Review
Cytology quality improvement is the subject of a recent article published in the Nov 2011 issue of the Archives of Pathology and Laboratory Medicine. Your homework (and mine) is to read this article, and then we will follow-up and discuss it. Click on the link to read and review the article. Bookmark this page, or set [...]

Recent Comments